טוען...

Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)

AIM: Evaluate long-term real-world treatment patterns and associated effectiveness and safety outcomes in patients with diabetic macular edema (DME) treated ≥36 months with 0.5mg ranibizumab. METHODS: Open-label observational effectiveness study in 9 Belgian clinics. Included were primary treated ey...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Clin Ophthalmol
Main Authors: Van Aken, Elisabeth, Favreau, Mérédis, Ramboer, Eva, Denhaerynck, Kris, MacDonald, Karen, Abraham, Ivo, Brié, Heidi
פורמט: Artigo
שפה:Inglês
יצא לאור: Dove 2020
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7720424/
https://ncbi.nlm.nih.gov/pubmed/33299294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S281501
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!